ea0029p1576 | Thyroid (non-cancer) | ICEECE2012
Anagnostis P.
, Adamidou F.
, Polyzos S.
, Katergari S.
, Karathanasi E.
, Zouli C.
, Panagiotou A.
, Kita M.
Introduction: Antithyroid drugs (ATD) remain the first-line therapy in patients with GravesÂ’ disease (GD), despite high relapse rate. The purpose of the present study was to identify predictors of long term remission of GD in patients who received ATD as primary treatment.Description of methods/design: We restrospectively identified patients with GravesÂ’ disease initially treated with ATD between 1984 and 2011 and extracted relevant data from t...